Immunogenicity and Efficacy ofCryptococcus neoformansCapsular Polysaccharide Glucuronoxylomannan Peptide Mimotope-Protein Conjugates in Human Immunoglobulin Transgenic Mice
Open Access
- 1 January 2004
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (1) , 196-208
- https://doi.org/10.1128/iai.72.1.196-208.2004
Abstract
Peptide mimotopes of capsular polysaccharides have been proposed as antigens for vaccines against encapsulated pathogens. In this study, we determined the antibody response to and efficacy of P13, a peptide mimetic of the Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan (GXM), in mice that produce human antibodies. P13 was conjugated to tetanus toxoid (TT) or diphtheria toxoid (DT) and administered subcutaneously in Alhydrogel with or without CpG to mice transgenic for human immunoglobulin loci (XenoMouse mice) and expressing either immunoglobulin G2 (IgG2) (G2 mice) or IgG4 (G4 mice). Mice were vaccinated and revaccinated two or three times. The serum antibody responses of the mice to GXM and P13 and antibody idiotype expression were analyzed by an enzyme-linked immunosorbent assay. The results showed that both P13-TT and P13-DT were antigenic, inducing a mimetic response to P13 in both G2 and G4 mice, and immunogenic, inducing a mimotope response including VH3 (idiotype)-positive antibodies to GXM in G2 but not G4 mice. CpG led to higher titers of IgG to P13 and GXM in P13-TT-vaccinated G2 mice. C. neoformans challenge of P13-protein conjugate-vaccinated and control G2 mice induced anamnestic IgG- and VH3-positive responses to GXM and was associated with a significantly decreased risk of death and a prolongation of survival in P13-DT-vaccinated mice compared to phosphate-buffered saline-treated or protein carrier-vaccinated mice. These findings reveal that P13 elicited a human antibody response with VH3 expression in human immunoglobulin transgenic mice that has been observed for human antibodies to GXM and support the concept that peptide mimotope-based vaccines may hold promise for the treatment of C. neoformans infections.Keywords
This publication has 102 references indexed in Scilit:
- Cryptococcus neoformansInfection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and OutcomeEmerging Infectious Diseases, 2001
- Cryptococcus neoformansInfection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and OutcomeEmerging Infectious Diseases, 2001
- Peptide Mimic of Phosphorylcholine, a Dominant Epitope Found onStreptococcus pneumoniaeInfection and Immunity, 2000
- Production of Protective Human Antipneumococcal Antibodies by Transgenic Mice with Human Immunoglobulin LociInfection and Immunity, 2000
- Normal human immunoglobulin G4 is bispecific: it has two different antigen‐combining sitesImmunology, 1999
- The Apparent Monovalency of Human IgG4 Is Due to BispecificityInternational Archives of Allergy and Immunology, 1999
- Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in miceNature Genetics, 1997
- Canonical Structure Repertoire of the Antigen-binding Site of Immunoglobulins Suggests Strong Geometrical Restrictions Associated to the Mechanism of Immune RecognitionJournal of Molecular Biology, 1995
- Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates. Description of a new lambda light chain-associated idiotype and the relation between idiotype expression, avidity, and vaccine formulation. The Collaborative Vaccine Study Group.Journal of Clinical Investigation, 1993
- Fc ReceptorsAnnual Review of Immunology, 1991